Torthaí cuardaigh - Colleen M. Niswender

Beachtaigh na torthaí
  1. 1
    RNA Editing of the Human Serotonin 5-HT2C Receptor Alterations in Suicide and Implications for Serotonergic Pharmacotherapy

    RNA Editing of the Human Serotonin 5-HT2C Receptor Alterations in Suicide and Implications for Serotonergic Pharmacotherapy de réir Colleen M. Niswender

    Foilsithe / Cruthaithe 2001
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  2. 2
    Progress toward advanced understanding of metabotropic glutamate receptors: structure, signaling and therapeutic indications

    Progress toward advanced understanding of metabotropic glutamate receptors: structure, signaling and therapeutic indications de réir Yin Shen, Colleen M. Niswender

    Foilsithe / Cruthaithe 2014
    Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  3. 3
    Metabotropic Glutamate Receptors: Physiology, Pharmacology, and Disease

    Metabotropic Glutamate Receptors: Physiology, Pharmacology, and Disease de réir Colleen M. Niswender, P. Jeffrey Conn

    Foilsithe / Cruthaithe 2010
    Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  4. 4
    Serotonin 5‐HT<sub>2C</sub> Receptor RNA Editing Alters Receptor Basal Activity

    Serotonin 5‐HT<sub>2C</sub> Receptor RNA Editing Alters Receptor Basal Activity de réir Katharine Herrick‐Davis, Ellinor Grinde, Colleen M. Niswender

    Foilsithe / Cruthaithe 1999
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  5. 5
    Novel pharmacological targets for GABAergic dysfunction in ADHD

    Novel pharmacological targets for GABAergic dysfunction in ADHD de réir Anthony S. Ferranti, Deborah J. Luessen, Colleen M. Niswender

    Foilsithe / Cruthaithe 2024
    Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  6. 6
    Mglur4-Positive Allosteric Modulation as Potential Treatment for Parkinson’s Disease

    Mglur4-Positive Allosteric Modulation as Potential Treatment for Parkinson’s Disease de réir Corey R. Hopkins, Craig W. Lindsley, Colleen M. Niswender

    Foilsithe / Cruthaithe 2009
    Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  7. 7
    Glutamate Receptors as Therapeutic Targets for Parkinsons Disease

    Glutamate Receptors as Therapeutic Targets for Parkinsons Disease de réir Kari A. Johnson, P. Jeffrey Conn, Colleen M. Niswender

    Foilsithe / Cruthaithe 2009
    Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  8. 8
    Opportunities and challenges in the discovery of allosteric modulators of GPCRs for treating CNS disorders

    Opportunities and challenges in the discovery of allosteric modulators of GPCRs for treating CNS disorders de réir P. Jeffrey Conn, Craig W. Lindsley, Jens Meiler, Colleen M. Niswender

    Foilsithe / Cruthaithe 2014
    Faigh an téacs iomlán Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  9. 9
    Metabotropic Glutamate Receptor 7: A New Therapeutic Target in Neurodevelopmental Disorders

    Metabotropic Glutamate Receptor 7: A New Therapeutic Target in Neurodevelopmental Disorders de réir Nicole M. Fisher, Mabel Seto, Craig W. Lindsley, Colleen M. Niswender

    Foilsithe / Cruthaithe 2018
    Faigh an téacs iomlán Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  10. 10
    Group III mGluR regulation of synaptic transmission at the SC-CA1 synapse is developmentally regulated

    Group III mGluR regulation of synaptic transmission at the SC-CA1 synapse is developmentally regulated de réir Jennifer Ayala, Colleen M. Niswender, Qingwei Luo, Jessica L. Banko, P. Jeffrey Conn

    Foilsithe / Cruthaithe 2007
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  11. 11
    RNA Editing of the Human Serotonin 5-Hydroxytryptamine 2C Receptor Silences Constitutive Activity

    RNA Editing of the Human Serotonin 5-Hydroxytryptamine 2C Receptor Silences Constitutive Activity de réir Colleen M. Niswender, Sara C. Copeland, Katharine Herrick‐Davis, Ronald B. Emeson, Elaine Sanders‐Bush

    Foilsithe / Cruthaithe 1999
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  12. 12
    RNA‐editing of the 5‐HT<sub>2C</sub> receptor alters agonist‐receptor‐effector coupling specificity

    RNA‐editing of the 5‐HT<sub>2C</sub> receptor alters agonist‐receptor‐effector coupling specificity de réir Kelly A. Berg, Jodie Cropper, Colleen M. Niswender, Elaine Sanders‐Bush, Ronald B. Emeson, William P. Clarke

    Foilsithe / Cruthaithe 2001
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  13. 13
    Discovery of a Novel Chemical Class of mGlu<sub>5</sub> Allosteric Ligands with Distinct Modes of Pharmacology

    Discovery of a Novel Chemical Class of mGlu<sub>5</sub> Allosteric Ligands with Distinct Modes of Pharmacology de réir Alexis S. Hammond, Alice L. Rodriguez, Steven D. Townsend, Colleen M. Niswender, Karen J. Gregory, Craig W. Lindsley, P. Jeffrey Conn

    Foilsithe / Cruthaithe 2010
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  14. 14
    Practical Strategies and Concepts in GPCR Allosteric Modulator Discovery: Recent Advances with Metabotropic Glutamate Receptors

    Practical Strategies and Concepts in GPCR Allosteric Modulator Discovery: Recent Advances with Metabotropic Glutamate Receptors de réir Craig W. Lindsley, Kyle A. Emmitte, Corey R. Hopkins, Thomas M. Bridges, Karen J. Gregory, Colleen M. Niswender, P. Jeffrey Conn

    Foilsithe / Cruthaithe 2016
    Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  15. 15
    Total RNA Sequencing of Rett Syndrome Autopsy Samples Identifies the M<sub>4</sub> Muscarinic Receptor as a Novel Therapeutic Target

    Total RNA Sequencing of Rett Syndrome Autopsy Samples Identifies the M<sub>4</sub> Muscarinic Receptor as a Novel Therapeutic Target de réir Rocco G. Gogliotti, Nicole M. Fisher, Branden J. Stansley, Carrie K. Jones, Craig W. Lindsley, P. Jeffrey Conn, Colleen M. Niswender

    Foilsithe / Cruthaithe 2018
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  16. 16
    Selective Actions of Novel Allosteric Modulators Reveal Functional Heteromers of Metabotropic Glutamate Receptors in the CNS

    Selective Actions of Novel Allosteric Modulators Reveal Functional Heteromers of Metabotropic Glutamate Receptors in the CNS de réir Yin Shen, Meredith J. Noetzel, Kari A. Johnson, Rocio Zamorano, Nidhi Jalan‐Sakrikar, Karen J. Gregory, P. Jeffrey Conn, Colleen M. Niswender

    Foilsithe / Cruthaithe 2013
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  17. 17
    Allosteric Modulation of Seven Transmembrane Spanning Receptors: Theory, Practice, and Opportunities for Central Nervous System Drug Discovery

    Allosteric Modulation of Seven Transmembrane Spanning Receptors: Theory, Practice, and Opportunities for Central Nervous System Drug Discovery de réir Bruce J. Melancon, Corey R. Hopkins, Michael R. Wood, Kyle A. Emmitte, Colleen M. Niswender, Arthur Christopoulos, P. Jeffrey Conn, Craig W. Lindsley

    Foilsithe / Cruthaithe 2011
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  18. 18
    Metabotropic glutamate receptor 3 activation is required for long-term depression in medial prefrontal cortex and fear extinction

    Metabotropic glutamate receptor 3 activation is required for long-term depression in medial prefrontal cortex and fear extinction de réir Adam G. Walker, Cody J. Wenthur, Zixiu Xiang, Jerri M. Rook, Kyle A. Emmitte, Colleen M. Niswender, Craig W. Lindsley, P. Jeffrey Conn

    Foilsithe / Cruthaithe 2015
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  19. 19
    A Novel Class of Succinimide-Derived Negative Allosteric Modulators of Metabotropic Glutamate Receptor Subtype 1 Provides Insight into a Disconnect in Activity between the Rat and Human Receptors

    A Novel Class of Succinimide-Derived Negative Allosteric Modulators of Metabotropic Glutamate Receptor Subtype 1 Provides Insight into a Disconnect in Activity between the Rat and... de réir Hyekyung P. Cho, Darren W. Engers, Daryl F. Venable, Colleen M. Niswender, Craig W. Lindsley, P. Jeffrey Conn, Kyle A. Emmitte, Alice L. Rodriguez

    Foilsithe / Cruthaithe 2014
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  20. 20
    Synthesis and Evaluation of a Series of Heterobiarylamides That Are Centrally Penetrant Metabotropic Glutamate Receptor 4 (mGluR4) Positive Allosteric Modulators (PAMs)

    Synthesis and Evaluation of a Series of Heterobiarylamides That Are Centrally Penetrant Metabotropic Glutamate Receptor 4 (mGluR4) Positive Allosteric Modulators (PAMs) de réir Darren W. Engers, Colleen M. Niswender, C. David Weaver, Satyawan Jadhav, Usha N. Menon, Rocio Zamorano, P. Jeffrey Conn, Craig W. Lindsley, Corey R. Hopkins

    Foilsithe / Cruthaithe 2009
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:

Uirlisí cuardaigh: